Over 220 experts from 27 countries came together to shape the future of radiotheranostics for better cancer patient outcomes. This biannual conference brought together a broad spectrum of stakeholders – from academia, industry, patient advocacy groups and professional associations to investors and philanthropists. Forty international experts shared their insights on the global evolution of theranostics, latest advancements in education and accreditation, the growth of the ICPO Theranostics Centers network, as well as radiopharmaceuticals game changers and the role of artificial intelligence (AI).